Last checked at 28 Jan 2021 14:42
IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test
IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Avacta Group Share News (AVCT)
AVCT Share
Price
AVCT Share
News
AVCT Share
Chat65
AVCT Share
Trades161
AVCT
Live RNS
AVCT Share
Charts
AVCT Level 2
Console
AVCT Live
Share Price
AVCT Broker
Ratings
AVCT Directors
Deals
AVCT Financial
Diary
AVCT
Fundamentals
AVCT Short
Positions1
AVCT
Media
Avacta Group Information
Share Price Information for Avacta Group (AVCT)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
44.50
Bid:
44.00
Ask:
45.00
Change:
-0.80 (-1.77%)
Spread:
1.00 (2.273%)
Open:
45.25
High:
45.25
Low:
44.25
Prev. Close:
45.30
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.7 Jan 2021 13:51
IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma
IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma
Read more7 Jan 2021 08:58
Avacta enters licence agreement with Point Biopharma
(Sharecast News) - Cancer therapy and diagnostics developer Avacta Group has entered into a licence agreement with Point Biopharma, it announced on Thursday, to provide access to its 'preCISION' technology for the development of tumour-activated radiopharmaceuticals.
Read more23 Dec 2020 19:50
UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost
UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost
Read more23 Dec 2020 08:56
Avacta submits clinical trial application for 'AVA6000' prodrug
(Sharecast News) - Cancer therapy developer Avacta Group has submitted a clinical trial application in the UK for a phase 1 first-in-human open label dose-escalation and expansion study of its lead 'preCISION' prodrug, 'AVA6000', in patients with locally-advanced or metastatic selected solid tumours, it announced on Wednesday.
Read more21 Dec 2020 18:10
UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain
UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain
Read more21 Dec 2020 09:49
Avacta enters 'Affimer' licensing deal with Astrea Bioseparations
(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a licensing agreement with Astrea Bioseparations, it announced on Monday, for the use of the 'Affimer' platform in affinity purification applications.
Read more23 Nov 2020 15:20
Avacta reports 'significant progress' on Covid-19 test
(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group announced "significant progress" in the development of a scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test being carried out with BBI Solutions on Monday.
Read more22 Oct 2020 15:53
UK DIRECTOR DEALINGS SUMMARY: Dunkerton Buys More Superdry Shares
UK DIRECTOR DEALINGS SUMMARY: Dunkerton Buys More Superdry Shares
Read more1 Oct 2020 06:40
IN BRIEF: Avacta Stock Continues Rise After Launch Of SARS-CoV-2 Test
IN BRIEF: Avacta Stock Continues Rise After Launch Of SARS-CoV-2 Test
Read more24 Sep 2020 15:43
UK's Integumen unveils prototype COVID-19 breath test
LONDON, Sept 24 (Reuters) - Integumen, a British company that developed a system to detect the COVID-19 virus in waste water, said the same technology could be deployed in a personalised breath test that could become an effective tool in fighting...
Read more21 Sep 2020 16:08
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more7 Sep 2020 14:28
IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test
IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test
Read more7 Sep 2020 12:55
Avacta launching Covid-19 laboratory test
(Sharecast News) - Biotherapeutics company Avacta Group announced on Monday that it will launch an 'ELISA' laboratory test for the SARS-CoV-2 spike protein, to support global research efforts into the coronavirus that causes Covid-19.
Read more2 Sep 2020 15:50
IN BRIEF: Avacta Expands Covid-19 Saliva Test Manufacturing Capacity
IN BRIEF: Avacta Expands Covid-19 Saliva Test Manufacturing Capacity
Read more